Sylvia E. Schwarz
Impact in
- Oncology top 5%
- Cancer-related Molecular Pathways
- Peptidase Inhibition and Analysis
- Molecular Biology top 5%
- Ubiquitin and proteasome pathways
- Protein Degradation and Inhibitors
- RNA modifications and cancer
- Glycosylation and Glycoproteins Research
Papers in
- Oncology 7
- Cancer-related Molecular Pathways 3
- CAR-T cell therapy research 3
- Cancer Immunotherapy and Biomarkers 2
-
- Ubiquitin and proteasome pathways 6
- Co-authors
- Martin Scheffner (5 shared papers)Gregory A. Cope (1 shared paper)Eugene V. Koonin (1 shared paper)L. Aravind (1 shared paper)S Lawrence Zipursky (1 shared paper)Greg S. B. Suh (1 shared paper)Raymond J. Deshaies (1 shared paper)Ulrike A. Nuber (2 shared papers)
- Journals
- Blood (3 papers)Journal of Biological Chemistry (2 papers)Hematological Oncology (1 paper)European Journal of Biochemistry (1 paper)Trials (1 paper)
- Partner nations
- United StatesGermanySpain
In The Last Decade
Sylvia E. Schwarz
12 papers receiving 1.7k citations
Sylvia E. Schwarz's Hit Papers
Peers
Comparison fields: 5 of 74
- Oncology 697
- Molecular Biology 1.4k
- Cell Biology 195
- Immunology 212
- Cancer Research 144
Countries citing papers authored by Sylvia E. Schwarz
This map shows the geographic impact of Sylvia E. Schwarz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvia E. Schwarz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvia E. Schwarz more than expected).
Fields of papers citing papers by Sylvia E. Schwarz
This network shows the impact of papers produced by Sylvia E. Schwarz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvia E. Schwarz. The network helps show where Sylvia E. Schwarz may publish in the future.
Co-authors
The 25 scholars most cited alongside Sylvia E. Schwarz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Role of Predicted Metalloprotease Motif of Jab1/Csn5 in Cleavage of Nedd8 from Cul1 Hit paper breakdown → | 2002 | 588 |
| 2 | 1999 | 437 | |
| 3 | 1998 | 192 | |
| 4 | 1998 | 152 | |
| 5 | 1996 | 136 | |
| 6 | 2020 | 115 | |
| 7 | 1998 | 108 | |
| 8 | 2018 | 13 | |
| 9 | 2020 | 9 | |
| 10 | 2023 | 9 | |
| 11 | 2019 | 8 | |
| 12 | 2018 | 3 |
About Sylvia E. Schwarz
Sylvia E. Schwarz is a scholar working on Oncology, Molecular Biology, Pathology and Forensic Medicine, Public Health, Environmental and Occupational Health and Immunology, having authored 12 papers that have together received 1.8k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (6 papers), Lymphoma Diagnosis and Treatment (5 papers), Cancer-related Molecular Pathways (3 papers), CAR-T cell therapy research (3 papers), Acute Lymphoblastic Leukemia research (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Immune Cell Function and Interaction (2 papers) and Genetics and Neurodevelopmental Disorders (1 paper). The work is most often cited by research in Oncology (697 citations), Molecular Biology (1.4k citations), Cell Biology (195 citations), Immunology (212 citations) and Cancer Research (144 citations). Sylvia E. Schwarz has collaborated with scholars based in United States, Germany and Spain. Frequent co-authors include Martin Scheffner, Gregory A. Cope, Eugene V. Koonin, L. Aravind, S Lawrence Zipursky, Greg S. B. Suh, Raymond J. Deshaies, Ulrike A. Nuber, Valentina Fogal and Arnd Hengstermann. Their work appears in journals such as Blood, Journal of Biological Chemistry, Hematological Oncology, European Journal of Biochemistry and Trials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.